| Dr Gerald R Theberge, DDS | |
|
72 High Street, Brattleboro, VT 05301 | |
| (802) 254-9644 | |
| (802) 257-8512 |
| Full Name | Dr Gerald R Theberge |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 72 High Street, Brattleboro, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376570226 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 0160000888 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerald R Theberge, DDS 72 High Street, Brattleboro, VT 05301 Ph: (802) 254-9644 | Dr Gerald R Theberge, DDS 72 High Street, Brattleboro, VT 05301 Ph: (802) 254-9644 |
News Archive
C Diff Foundation is proud to present the 2014 "Raising C.difficile Awareness" conference. Join us November 4th at 8 a.m. – 5 p.m. at the University of Illinois at Chicago, Student Center, West 828 S. Wolcott Avenue, Thompson Room, Chicago, IL.
The Springer journal Analytical and Bioanalytical Chemistry (ABC) has chosen Jean-Philippe Frimat (29) as the recipient of its Best Paper Award 2009. Frimat is the lead author of a paper in ABC on plasma stencilling methods for cell patterning.
Researchers at the New York University School of Medicine and NYU Langone Health Center have found a new organ so to speak, that can be one of the largest in the body based on its structure and distribution. This part of the body is called the interstitium and is an already known space in the body that comprises of fluid filled spaces that spans all over the body.
A recent report from the U.S. surgeon general on bone health and osteoporosis has found that black women have a lower risk of fracture than white women at every level of bone mineral density.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 4 days ago
Dr. Suzanne Beth West, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 93 High St, Brattleboro, VT 05301 Phone: 802-254-4770 Fax: 802-254-3630 | |
Janet K Zinter, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 63 Western Ave, Suite 1, Brattleboro, VT 05301 Phone: 802-254-4190 | |
Martina Howe, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 72 Landmark Hill Dr, Brattleboro, VT 05301 Phone: 802-254-9244 | |
Dr. Jeremy Seth Hoffman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 31 Fairview St, Brattleboro, VT 05301 Phone: 802-257-1700 | |
Dr. Paul G Stone, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 72 Landmark Hill Dr, Brattleboro, VT 05301 Phone: 802-254-3618 | |
Dr. Eric William El Masri, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 927 Putney Rd, Brattleboro, VT 05301 Phone: 802-342-4633 |